![Incotec](/mediaassets/images/corporate/our-brands/incotec/incotec-innovation-centre-enkhuizen.jpg?w=1920&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=01C8FD1F10DC9CF56218D78340B69396)
Netherlands
Our seed enhancement business Incotec is based in the Netherlands, with an innovation centre, manufacturing site and sales offices at its head office in Enkhuizen.
Incotec Europe
Westeinde 107 1601 BLEnkhuizen
The Netherlands
Tel: +31 (0)228 358000
Tel: +31 (0)228 358000
Further reading
![Danuta Gray](/mediaassets/images/corporate/news/danuta-gray.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=4E48F0E0B0E04194C80E110FED527420)
Appointment of Chair Designate
22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate
![](/mediaassets/images/corporate/news/dsc00581.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=643B87E09825A7A47016A19D54479CFF)
Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company
Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...
![Laboratory work](/mediaassets/images/corporate/shutterstock-1431826262.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=7BA9F7A82C598C9588A2A8A19234BDAA)
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.
![](/mediaassets/images/corporate/news/aris.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=2936B1AA3E6E925A06B712762F30717B)
Sustainability expert Aris Vrettos joins Croda
The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...